Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
1.
Microbiol Spectr ; 10(5): e0169722, 2022 10 26.
Article de Anglais | MEDLINE | ID: mdl-36190424

RÉSUMÉ

Multidrug-resistant (MDR) Pseudomonas aeruginosa increasingly causes health care-associated infections. In this study, we determined the activity of ceftolozane-tazobactam, ceftazidime-avibactam, and cefiderocol against 223 MDR P. aeruginosa clinical isolates recovered from 2013 to 2017 at the University Hospital Frankfurt by using MIC test strips. Furthermore, we evaluated the presence of genes encoding major ß-lactamases, such as VIM, IMP, NDM, GIM, SPM, and KPC; the extended spectrum ß-lactamase (ESBL)-carbapenemase GES; and the virulence-associated traits ExoS and ExoU, as in particular ExoU is thought to be associated with poor clinical outcome. For MDR P. aeruginosa isolates, the MIC50/MIC90 values of ceftolozane-tazobactam, ceftazidime-avibactam, and cefiderocol were 8/>256 mg/L, 16/>256 mg/L, and 0.25/1 mg/L, respectively. Cefiderocol showed the highest susceptibility rate (97.3%) followed by ceftazidime-avibactam (48.4%) and ceftolozane-tazobactam (46.6%). In 81 (36.3%) isolates, carbapenemase gene blaVIM was detected, and in 5 (2.2%) isolates, blaGES was detected (with a positive association of exoU and blaVIM). More than half of the isolates belong to the so-called international P. aeruginosa "high-risk" clones, with sequence type 235 (ST235) (24.7%) being the most prevalent. This study underlines that ceftolozane-tazobactam, ceftazidime-avibactam, and cefiderocol are important options for the treatment of infections due to MDR P. aeruginosa, with cefiderocol currently being the most active available antipseudomonal ß-lactam agent. According to our clinical experience, the outcome of cefiderocol therapy (8 patients) was favorable especially in cases of MDR P. aeruginosa-associated complicated urinary tract infections. IMPORTANCE After testing ceftolozane-tazobactam, ceftazidime-avibactam, and cefiderocol against a collection of 233 multidrug-resistant (MDR) Pseudomonas aeruginosa, we showed that cefiderocol is the most active antipseudomonal ß-lactam agent (susceptibility rates were 46.6%, 48.4%, and 97.4%, respectively). The most prevalent one was sequence type 235 (ST235) (24.7%), followed by ST244, ST175, and ST233, with all belonging to the top 10 P. aeruginosa high-risk clones with worldwide distribution. Our data indicate that during surveillance studies special attention should be paid to the MDR and highly virulent VIM- and ExoU-producing variant of ST235. Furthermore, in the case of infections caused by carbapenemase-producing MDR P. aeruginosa, cefiderocol is the preferred treatment option, while outcomes of complicated urinary tract infections and hospital-acquired pneumonia with cefiderocol were favorable.


Sujet(s)
Infections à Pseudomonas , Pseudomonas aeruginosa , Humains , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , bêta-Lactamases/génétique , Ceftazidime/pharmacologie , Ceftazidime/usage thérapeutique , Céphalosporines/pharmacologie , Céphalosporines/usage thérapeutique , Multirésistance bactérienne aux médicaments , Hôpitaux , Tests de sensibilité microbienne , Pseudomonas aeruginosa/génétique , Infections à Pseudomonas/traitement médicamenteux , Tazobactam/pharmacologie , Tazobactam/usage thérapeutique ,
2.
Aust Vet J ; 2020 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-33289077

RÉSUMÉ

Fetal loss and lamb mortality between mid-pregnancy and weaning are important economic and welfare issues for the Australian sheep industry. The aim of this study was to determine common causes of ovine abortion and stillbirths based on submissions to veterinary laboratories and identify factors that impact the determination of an aetiological diagnosis. Data for 529 investigations on abortion or stillbirth between 2000 and 2018 were retrieved from four state veterinary laboratories in Western Australia, South Australia, Victoria and Tasmania. An aetiological diagnosis was made for 57% of investigations. Investigations that included placental tissue samples were more than twice as likely to have an aetiological diagnosis compared to investigations without placenta (P = 0.017, 95% confidence interval 1.1, 4.5). Of the investigations where an aetiological diagnosis was made, 81% involved infectious abortion, with Campylobacter spp. (32%), Listeria spp. (25%) and Toxoplasma gondii (9%) being the three most common abortigenic pathogens implicated. The remaining 19% of investigations with an aetiological diagnosis included a wide range of infectious and non-infectious diseases. Diagnoses made varied year to year and between states. No evidence of exotic abortigenic pathogens were reported. Veterinary practitioners can improve the probability of an aetiological diagnosis by emphasising to farmers the importance of collecting any aborted material, especially placenta, and appropriate storage of the tissues until they can be submitted to the laboratory. Some diseases that cause abortion in Australian sheep have zoonotic potential, and veterinary practitioners play an important role in educating clients about appropriate hygiene when handling pregnant and lambing ewes or any aborted material.

3.
Chirurg ; 78(12): 1148-51, 2007 Dec.
Article de Allemand | MEDLINE | ID: mdl-17431554

RÉSUMÉ

Streptococcus agalactiae, known as a pathogen that causes meningitis and septicemia in neonates, emerges as an invasive organism in nonpregnant adults. This case report describes the fulminant course of a necrotizing fasciitis (NF) with streptococcal toxic shock-like syndrome (STSS) in a 76-year-old diabetic patient caused by S. agalactiae, serotype V. Chronic diseases and immunodeficiency are considered to be risk factors for the acquisition of group B streptococcal disease. Since early surgical treatment in conjunction with antimicrobial and intensive care therapy is critical for the outcome of patients with NF and/or STSS, clinicians should be aware of invasive S. agalactiae infections in adults with subcutaneous emphysema.


Sujet(s)
Abcès/chirurgie , Fasciite nécrosante/chirurgie , Ostéosynthèse interne , Fractures de la hanche/chirurgie , Complications postopératoires/étiologie , Infections à streptocoques/chirurgie , Streptococcus agalactiae , Emphysème sous-cutané/étiologie , Infection de plaie opératoire/chirurgie , Sujet âgé , Antibactériens , Soins de réanimation , Débridement , Diagnostic différentiel , Association de médicaments , Issue fatale , Femelle , Humains , Réintervention , Choc septique/diagnostic , Choc septique/chirurgie
4.
Chirurg ; 76(10): 983-6, 2005 Oct.
Article de Allemand | MEDLINE | ID: mdl-16021394

RÉSUMÉ

Atraumatic infections due to Clostridium septicum are known to be associated with immunosuppression or even malignancy. In this case report, we present a patient with severe Clostridium septicum infection related to advanced colon cancer that had not previously been diagnosed. The case demonstrates the strong association between Clostridium septicum infections and malignancy, particularly in the presence of other predisposing diseases such as diabetes mellitus. It strongly suggests excluding malignant neoplasms, especially of the gastrointestinal tract, when severe Clostridium septicum infections occur. Moreover, if patients with known colorectal or other malignancy develop septicaemia or spontaneous gas gangrene, clinicians should be aware of Clostridium septicum as one of the main causative agents, as early diagnosis and aggressive treatment are important to improve prognosis.


Sujet(s)
Adénocarcinome/complications , Clostridium/isolement et purification , Tumeurs du côlon/complications , Diabète de type 2/complications , Gangrène gazeuse/étiologie , Syndromes paranéoplasiques , Adénocarcinome/diagnostic , Adénocarcinome/traitement médicamenteux , Adénocarcinome/secondaire , Adénocarcinome/chirurgie , Antibactériens/administration et posologie , Antibactériens/usage thérapeutique , Ponction-biopsie à l'aiguille , Traitement médicamenteux adjuvant , Clindamycine/administration et posologie , Clindamycine/usage thérapeutique , Colectomie , Tumeurs du côlon/diagnostic , Tumeurs du côlon/traitement médicamenteux , Tumeurs du côlon/chirurgie , Coloscopie , Débridement , Association de médicaments , Gangrène gazeuse/diagnostic , Gangrène gazeuse/imagerie diagnostique , Gangrène gazeuse/traitement médicamenteux , Gangrène gazeuse/microbiologie , Gangrène gazeuse/chirurgie , Humains , Foie/anatomopathologie , Tumeurs du foie/anatomopathologie , Tumeurs du foie/secondaire , Mâle , Adulte d'âge moyen , Stadification tumorale , Pénicillines/administration et posologie , Pénicillines/usage thérapeutique , Radiographie , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE